Anticancer Drug Release System Based on Hollow Silica Nanocarriers Triggered by Tumor Cellular Microenvironments

Shaoxin Deng1,2, Cheng-Xing Cui1,3, Lingyao Duan1

  • 1Postdoctoral Research Base, School of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.

ACS Omega
|January 18, 2021
PubMed

Insights

This study details a pH-responsive drug delivery system using amino-functionalized silica nanoparticles for targeted anticancer drug release. The system shows efficient drug loading and release, demonstrating potential for cancer therapy.

Area of Science:

  • Nanotechnology
  • Oncology
  • Materials Science

Background:

  • Targeted drug delivery to tumors is crucial in oncology.
  • pH-responsive systems offer controlled release in tumor microenvironments.
  • Current systems require intelligent design for enhanced efficacy.

Purpose of the Study:

  • To design and detail a pH-responsive drug delivery system.
  • To utilize amino-functionalized hollow mesoporous silica nanoparticles as carriers.
  • To evaluate the drug release behavior in simulated tumor microenvironments.

Main Methods:

  • In situ amino-functionalization of hollow mesoporous silica nanoparticles.
  • Loading of anticancer drugs (Zorubicin hydrochloride).
  • In vitro evaluation of drug release at pH 5.0.

Main Results:

  • The developed system demonstrated efficient drug loading.
  • Targeted and controllable drug release was observed.
  • Zorubicin hydrochloride release reached nearly 100% at pH 5.0.

Conclusions:

  • The pH-responsive drug delivery system shows significant potential for anticancer therapy.
  • Amino-functionalized silica nanoparticles are effective carriers for targeted drug release.
  • The system's sensitivity to acidic tumor microenvironments enables controlled drug delivery.